Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection

William Osburn, Brian E. Fisher, Kimberly A. Dowd, Giselle Urban, Lin Liu, Stuart Campbell Ray, David L Thomas, Andrea Cox

Research output: Contribution to journalArticle

Abstract

Background & Aims: We followed patients with ongoing hepatitis C virus (HCV) exposure following control of an initial HCV infection to determine whether primary control conferred protection against future persistent infections. Methods: Twenty-two active injection drug users (IDU) who had cleared a primary hepatitis C viremia for at least 60 days were monitored monthly. Reinfection was defined as the detection of a new HCV infection. Protection was assessed based on the magnitude and duration of viremia following reinfection and generation of T-cell and neutralizing antibody (nAb) responses. Results: Reinfection occurred in 11 IDU (50%) who previously spontaneously controlled primary HCV infection. Although viral clearance occurs in approximately 25% of patients with primary infections, spontaneous viral clearance was observed in 83% of reinfected patients. The duration and maximum level of viremia during subsequent episodes of reinfection were significantly decreased compared with those of the primary infection in the same subjects. In contrast to chronic infection, reinfection was associated with a significant increase in the breadth of T-cell responses. During acute infection, nAbs against heterologous viral pseudoparticles were detected in 60% of reinfected subjects; cross-reactive nAbs are rarely detected in patients who progress to chronic infection. Conclusions: HCV reinfection is associated with a reduction in the magnitude and duration of viremia (compared with the initial infection), broadened cellular immune responses, and generation of cross-reactive humoral responses. These findings are consistent with development of adaptive immunity that is not sterilizing but protects against chronic disease.

Original languageEnglish (US)
Pages (from-to)315-324
Number of pages10
JournalGastroenterology
Volume138
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Virus Diseases
Hepacivirus
Immunity
Viremia
Infection
Drug Users
T-Lymphocytes
Injections
Adaptive Immunity
Hepatitis C
Neutralizing Antibodies
Cellular Immunity
Antibody Formation
Chronic Disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection. / Osburn, William; Fisher, Brian E.; Dowd, Kimberly A.; Urban, Giselle; Liu, Lin; Ray, Stuart Campbell; Thomas, David L; Cox, Andrea.

In: Gastroenterology, Vol. 138, No. 1, 01.2010, p. 315-324.

Research output: Contribution to journalArticle

@article{56a203e53c734f449bc2432c8d75d84e,
title = "Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection",
abstract = "Background & Aims: We followed patients with ongoing hepatitis C virus (HCV) exposure following control of an initial HCV infection to determine whether primary control conferred protection against future persistent infections. Methods: Twenty-two active injection drug users (IDU) who had cleared a primary hepatitis C viremia for at least 60 days were monitored monthly. Reinfection was defined as the detection of a new HCV infection. Protection was assessed based on the magnitude and duration of viremia following reinfection and generation of T-cell and neutralizing antibody (nAb) responses. Results: Reinfection occurred in 11 IDU (50{\%}) who previously spontaneously controlled primary HCV infection. Although viral clearance occurs in approximately 25{\%} of patients with primary infections, spontaneous viral clearance was observed in 83{\%} of reinfected patients. The duration and maximum level of viremia during subsequent episodes of reinfection were significantly decreased compared with those of the primary infection in the same subjects. In contrast to chronic infection, reinfection was associated with a significant increase in the breadth of T-cell responses. During acute infection, nAbs against heterologous viral pseudoparticles were detected in 60{\%} of reinfected subjects; cross-reactive nAbs are rarely detected in patients who progress to chronic infection. Conclusions: HCV reinfection is associated with a reduction in the magnitude and duration of viremia (compared with the initial infection), broadened cellular immune responses, and generation of cross-reactive humoral responses. These findings are consistent with development of adaptive immunity that is not sterilizing but protects against chronic disease.",
author = "William Osburn and Fisher, {Brian E.} and Dowd, {Kimberly A.} and Giselle Urban and Lin Liu and Ray, {Stuart Campbell} and Thomas, {David L} and Andrea Cox",
year = "2010",
month = "1",
doi = "10.1053/j.gastro.2009.09.017",
language = "English (US)",
volume = "138",
pages = "315--324",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection

AU - Osburn, William

AU - Fisher, Brian E.

AU - Dowd, Kimberly A.

AU - Urban, Giselle

AU - Liu, Lin

AU - Ray, Stuart Campbell

AU - Thomas, David L

AU - Cox, Andrea

PY - 2010/1

Y1 - 2010/1

N2 - Background & Aims: We followed patients with ongoing hepatitis C virus (HCV) exposure following control of an initial HCV infection to determine whether primary control conferred protection against future persistent infections. Methods: Twenty-two active injection drug users (IDU) who had cleared a primary hepatitis C viremia for at least 60 days were monitored monthly. Reinfection was defined as the detection of a new HCV infection. Protection was assessed based on the magnitude and duration of viremia following reinfection and generation of T-cell and neutralizing antibody (nAb) responses. Results: Reinfection occurred in 11 IDU (50%) who previously spontaneously controlled primary HCV infection. Although viral clearance occurs in approximately 25% of patients with primary infections, spontaneous viral clearance was observed in 83% of reinfected patients. The duration and maximum level of viremia during subsequent episodes of reinfection were significantly decreased compared with those of the primary infection in the same subjects. In contrast to chronic infection, reinfection was associated with a significant increase in the breadth of T-cell responses. During acute infection, nAbs against heterologous viral pseudoparticles were detected in 60% of reinfected subjects; cross-reactive nAbs are rarely detected in patients who progress to chronic infection. Conclusions: HCV reinfection is associated with a reduction in the magnitude and duration of viremia (compared with the initial infection), broadened cellular immune responses, and generation of cross-reactive humoral responses. These findings are consistent with development of adaptive immunity that is not sterilizing but protects against chronic disease.

AB - Background & Aims: We followed patients with ongoing hepatitis C virus (HCV) exposure following control of an initial HCV infection to determine whether primary control conferred protection against future persistent infections. Methods: Twenty-two active injection drug users (IDU) who had cleared a primary hepatitis C viremia for at least 60 days were monitored monthly. Reinfection was defined as the detection of a new HCV infection. Protection was assessed based on the magnitude and duration of viremia following reinfection and generation of T-cell and neutralizing antibody (nAb) responses. Results: Reinfection occurred in 11 IDU (50%) who previously spontaneously controlled primary HCV infection. Although viral clearance occurs in approximately 25% of patients with primary infections, spontaneous viral clearance was observed in 83% of reinfected patients. The duration and maximum level of viremia during subsequent episodes of reinfection were significantly decreased compared with those of the primary infection in the same subjects. In contrast to chronic infection, reinfection was associated with a significant increase in the breadth of T-cell responses. During acute infection, nAbs against heterologous viral pseudoparticles were detected in 60% of reinfected subjects; cross-reactive nAbs are rarely detected in patients who progress to chronic infection. Conclusions: HCV reinfection is associated with a reduction in the magnitude and duration of viremia (compared with the initial infection), broadened cellular immune responses, and generation of cross-reactive humoral responses. These findings are consistent with development of adaptive immunity that is not sterilizing but protects against chronic disease.

UR - http://www.scopus.com/inward/record.url?scp=72249087933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72249087933&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2009.09.017

DO - 10.1053/j.gastro.2009.09.017

M3 - Article

VL - 138

SP - 315

EP - 324

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 1

ER -